Passage Bio, Inc. (PASG)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

TWO COMMERCE SQUARE PHILADELPHIA, PA 19103

Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a portfolio of six life transforming AAV-delivered therapeutics for the treatment of rare monogenic central nervous system diseases.

Data as of 2020-05-30
Market Cap999.076 Million Shares Outstanding45.351 Million Avg 30-day Volume139.434 Thousand
P/E Ratio Dividend Yield EPS-2.58
Price/Sales Price cash flow ratio Price free cash flow ratio-16.7
Book Value8.53 Price to Tangible Book2.7 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low26.0 / 8.09 Stddev
View SEC Filings from PASG instead.

View recent insider trading info

Funds Holding PASG (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PASG BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RATCLIFFE LIAM

  • Director
686,500 2020-05-26 5

COUNTOURIOTIS ATHENA PRESIDENT & CEO

  • Officer
  • Director
26,872 2020-05-21 4

YAMADA TADATAKA

  • Director
0 2020-05-21 3

SQUINTO STEPHEN P

  • Director
  • 10% Owner
0 2020-05-20 2

KAPADIA SANDIP CFO AND TREASURER

  • Officer
29,832 2020-04-01 3

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VII LLC

  • Director
  • 10% Owner
2,532,402 2020-03-12 1

MORRIS RICHARD STEVEN CHIEF FINANCIAL OFFICER

  • Officer
400 2020-03-03 3

QUIGLEY JILL M. CHIEF OPERATING OFFICER

  • Officer
312,494 2020-03-03 3

GOLDSMITH BRUCE A CEO AND PRESIDENT

  • Officer
  • Director
1,100 2020-03-03 2

HERON PATRICK J

  • Director
  • 10% Owner
5,009,219 2020-03-03 3

ISLAM SAQIB

  • Director
5,000 2020-03-03 3

CALE EDGAR B. GC AND CORPORATE SECRETARY

  • Officer
2,000 2020-03-03 3

FRAZIER LIFE SCIENCES IX, L.P.

FHMLS IX, L.P.

FHMLS IX, L.L.C.

TOPPER JAMES N

  • 10% Owner
5,009,219 2020-03-03 1

WOIWODE THOMAS

  • Director
  • 10% Owner
4,959,769 2020-03-03 4

VERSANT VENTURE CAPITAL VI, L.P.

VERSANT VENTURES VI GP, L.P.

VERSANT VENTURES VI GP-GP, LLC

VERSANT VANTAGE I, L.P.

VERSANT VANTAGE I GP, L.P.

VERSANT VANTAGE I GP-GP, LLC

WOIWODE THOMAS

  • Director
  • 10% Owner
4,959,769 2020-03-03 4

FOTOPOULOS ALEXANDROS CHIEF TECHNICAL OFFICER

  • Officer
5,500 2020-03-03 3

ROMANO GARY CHIEF MEDICAL OFFICER

  • Officer
0 2020-02-27 2

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments